Delivery Order SPE2DB22D2007-SPE2DB25FH9WT

Award Date 3/14/25
Potential Completion Date 4/4/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,370.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BENLYSTA 120 MG VIALS, a specialty medication, with a completion date of March 19, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 400 MG VIALS to the Defense Logistics Agency (DLA). The contract, valued at $11,213.60, is a firm fixed price delivery order with a period of performance through July 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,790.98, is a delivery order for the supply of BENLYSTA 200 mg/mL syringes. It is a firm-fixed-price contract with a completion date of November 27, 2024. The contract is not designated as a set-aside and represents an open competition. Amerisourcebergen holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $5,038.00 fixed-price delivery order is for the supply of BENLYSTA 400 MG VIALS, a prescription medication, with a period of performance through June 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,790.98 firm fixed-price delivery order is for BENLYSTA 200 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $6,165.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BENLYSTA 200 MG/ML AUTOINJEC ML, a pharmaceutical product. The contract has a period of performance through February 13, 2025 and is structured as a firm fixed-price delivery order. This award does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,098.52, is for the delivery of BENLYSTA 400 MG vials, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 14, 2025. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,774.88 firm fixed-price delivery order is for BENLYSTA 200 MG/ML SYRINGEML, a specialty medication, with a completion date of January 9, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $1,259.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the supply of BENLYSTA 400 MG VIALS, a specialty pharmaceutical product. This award falls under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to...
This federal contract award, valued at $3,082.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, a Delivery Order contract, is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH9WT
    Delivery Order

This federal contract award, valued at $13,148.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BENLYSTA 400 MG VIALS, a specialty medication, with a period of performance through April 4, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed is a delivery order under this larger IDC. No set-aside designations were used for this award.

Generated 6/13/25, 9:42 AM